Nika Pharmaceuticals, Inc
NIKA· OTC
NIKANika Pharmaceuticals, Inc
Filed Apr 1, 2024 · 10-K · 92 days after period end · 0001826466-24-000041
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — |
| Net Income | -$46.45K | -$6.34M | -$3.30K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nika Pharmaceuticals, Inc · CIK 1145604 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Apr 1, 2024 · 92 d after period end
